No insider purchase over the last 90 days. The latest, by Cor Group Oy, was filed 21 May 2026.
This page follows insider dealings at Nightingale Health Oyj as filed with Nasdaq Helsinki, a company from the Health Care sector based in Helsinki, Finland. From 23 October 2025 to 23 October 2026, the disclosure feed for Nightingale Health Oyj logged 1 filing by 1 insider.
Only purchases show up on the open market, 1 purchase in all worth €5.0M, filed by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €5.0M, the purchase published on 21 May 2026 by Cor Group Oy is the largest of the period (8.7% of market cap).
Compared with its exchange (125 companies, median 15 filings), a count of 1 filing is below the norm. Since 2021, the database holds 5 purchases and no sales by insiders of the company.
The last insider purchase was made public on 21 May 2026, 156 days ago.
For comparison within the same sector, see the insider buying recorded at EssilorLuxottica and Dynavox Group AB. Every figure here comes from the filings published by Nasdaq Helsinki and describes the past, not future prices; it is not investment advice.
Headquarters: Helsinki, Finland
Source: Wikidata (CC0).
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Nightingale Health Oyj Buy (bullish), based on 1 analysts. Average price target: €1.30.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2026 · cache
25 of 45 declarations
Nightingale Health Oyj is a company in the health and pharmaceuticals sector, listed on the XHEL market. It focuses on biomarker analysis to enhance disease prevention and treatment.
Purchases our model currently ranks for the recommendations list.
All recommendations